T1	Outcomes 0 13	Effectiveness
T2	Outcomes 238 259	active androgen level
T3	Outcomes 471 479	efficacy
T4	Outcomes 1166 1174	Efficacy
T5	Outcomes 1191 1216	facial acne lesion counts
T6	Outcomes 1236 1253	global assessment
T7	Outcomes 1257 1282	subject's self-assessment
T8	Outcomes 1303 1353	within-cycle variation (cycle 6) in lesion counts.
T9	Outcomes 1477 1488	improvement
T10	Outcomes 1551 1593	mean decrease in inflammatory lesion count
T11	Outcomes 1677 1712	mean decrease in total lesion count
T12	Outcomes 1814 1846	investigator's global assessment
T13	Outcomes 1995 2147	secondary efficacy measures (total comedones, open comedones, closed comedones, papules, pustules, and the subject's self-assessment of study treatment)
T14	Outcomes 2351 2405	safe and effective treatment of moderate acne vulgaris
